JP2011000045A - Medium for detecting lactic acid bacterium and detection method - Google Patents
Medium for detecting lactic acid bacterium and detection method Download PDFInfo
- Publication number
- JP2011000045A JP2011000045A JP2009145278A JP2009145278A JP2011000045A JP 2011000045 A JP2011000045 A JP 2011000045A JP 2009145278 A JP2009145278 A JP 2009145278A JP 2009145278 A JP2009145278 A JP 2009145278A JP 2011000045 A JP2011000045 A JP 2011000045A
- Authority
- JP
- Japan
- Prior art keywords
- lactic acid
- medium
- acid bacteria
- detecting
- growth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title claims abstract description 244
- 241000894006 Bacteria Species 0.000 title claims abstract description 130
- 239000004310 lactic acid Substances 0.000 title claims abstract description 122
- 235000014655 lactic acid Nutrition 0.000 title claims abstract description 122
- 238000001514 detection method Methods 0.000 title claims description 16
- 238000000034 method Methods 0.000 claims abstract description 21
- 108090000790 Enzymes Proteins 0.000 claims abstract description 15
- 102000004190 Enzymes Human genes 0.000 claims abstract description 15
- 239000000758 substrate Substances 0.000 claims abstract description 12
- 102000005936 beta-Galactosidase Human genes 0.000 claims abstract description 11
- 108010005774 beta-Galactosidase Proteins 0.000 claims abstract description 11
- 239000003966 growth inhibitor Substances 0.000 claims abstract description 8
- 229930027917 kanamycin Natural products 0.000 claims description 19
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 claims description 19
- 229960000318 kanamycin Drugs 0.000 claims description 18
- 229930182823 kanamycin A Natural products 0.000 claims description 18
- 239000002647 aminoglycoside antibiotic agent Substances 0.000 claims description 6
- 230000000813 microbial effect Effects 0.000 claims description 6
- 239000003002 pH adjusting agent Substances 0.000 claims description 5
- 238000012258 culturing Methods 0.000 claims description 4
- 230000001737 promoting effect Effects 0.000 claims description 3
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical group O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 claims description 2
- 229940126574 aminoglycoside antibiotic Drugs 0.000 claims 2
- 230000003115 biocidal effect Effects 0.000 claims 1
- 235000013305 food Nutrition 0.000 abstract description 19
- 244000005700 microbiome Species 0.000 abstract description 11
- 235000013361 beverage Nutrition 0.000 abstract description 8
- 238000004519 manufacturing process Methods 0.000 abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 7
- 239000002609 medium Substances 0.000 description 86
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 22
- 229920001817 Agar Polymers 0.000 description 20
- 239000008272 agar Substances 0.000 description 20
- 235000010419 agar Nutrition 0.000 description 19
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 11
- 239000001569 carbon dioxide Substances 0.000 description 11
- 229910002092 carbon dioxide Inorganic materials 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 241000186660 Lactobacillus Species 0.000 description 9
- 229940039696 lactobacillus Drugs 0.000 description 9
- 239000000306 component Substances 0.000 description 8
- 239000007789 gas Substances 0.000 description 8
- 239000001963 growth medium Substances 0.000 description 8
- 238000007689 inspection Methods 0.000 description 8
- 239000006161 blood agar Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 241000186000 Bifidobacterium Species 0.000 description 6
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 6
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 6
- 239000000835 fiber Substances 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 description 3
- 241000194033 Enterococcus Species 0.000 description 3
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 3
- 241000192001 Pediococcus Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 239000007640 basal medium Substances 0.000 description 3
- 235000013405 beer Nutrition 0.000 description 3
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 229920001542 oligosaccharide Polymers 0.000 description 3
- 150000002482 oligosaccharides Chemical class 0.000 description 3
- -1 organic acid salts Chemical class 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 229940104230 thymidine Drugs 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- CHRVKCMQIZYLNM-MBJXGIAVSA-N (2s,3r,4s,5r,6r)-2-[(5-bromo-6-chloro-1h-indol-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC(Cl)=C(Br)C=C12 CHRVKCMQIZYLNM-MBJXGIAVSA-N 0.000 description 2
- OLXZPDWKRNYJJZ-UHFFFAOYSA-N 5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol Chemical compound C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(CO)O1 OLXZPDWKRNYJJZ-UHFFFAOYSA-N 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 229930182566 Gentamicin Natural products 0.000 description 2
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- 240000001046 Lactobacillus acidophilus Species 0.000 description 2
- 244000199885 Lactobacillus bulgaricus Species 0.000 description 2
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 description 2
- 241000194036 Lactococcus Species 0.000 description 2
- 241000192132 Leuconostoc Species 0.000 description 2
- 241000192130 Leuconostoc mesenteroides Species 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 241000194020 Streptococcus thermophilus Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 238000011481 absorbance measurement Methods 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 229930182830 galactose Natural products 0.000 description 2
- 229960002518 gentamicin Drugs 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000013622 meat product Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229940062057 nitrogen 80 % Drugs 0.000 description 2
- 235000006408 oxalic acid Nutrition 0.000 description 2
- 239000007793 ph indicator Substances 0.000 description 2
- 235000021110 pickles Nutrition 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
- 235000013580 sausages Nutrition 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000015041 whisky Nutrition 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- OQWBAXBVBGNSPW-RKQHYHRCSA-N (2s,3r,4s,5s,6r)-2-[(6-chloro-1h-indol-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC(Cl)=CC=C12 OQWBAXBVBGNSPW-RKQHYHRCSA-N 0.000 description 1
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- UHXLXOOPBSHMQJ-UHFFFAOYSA-M 10-dodecyl-3-n,3-n,6-n,6-n-tetramethylacridin-10-ium-3,6-diamine;bromide Chemical compound [Br-].C1=C(N(C)C)C=C2[N+](CCCCCCCCCCCC)=C(C=C(C=C3)N(C)C)C3=CC2=C1 UHXLXOOPBSHMQJ-UHFFFAOYSA-M 0.000 description 1
- YKBGVTZYEHREMT-KVQBGUIXSA-N 2'-deoxyguanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 YKBGVTZYEHREMT-KVQBGUIXSA-N 0.000 description 1
- YKBGVTZYEHREMT-UHFFFAOYSA-N 2'-deoxyguanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1CC(O)C(CO)O1 YKBGVTZYEHREMT-UHFFFAOYSA-N 0.000 description 1
- MXHRCPNRJAMMIM-SHYZEUOFSA-N 2'-deoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-SHYZEUOFSA-N 0.000 description 1
- KUWPCJHYPSUOFW-YBXAARCKSA-N 2-nitrophenyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1[N+]([O-])=O KUWPCJHYPSUOFW-YBXAARCKSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000186148 Bifidobacterium pseudolongum Species 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 241000206594 Carnobacterium Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000588914 Enterobacter Species 0.000 description 1
- 241000147019 Enterobacter sp. Species 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- 241000194031 Enterococcus faecium Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000191070 Escherichia coli ATCC 8739 Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 229930010555 Inosine Natural products 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- 239000004201 L-cysteine Substances 0.000 description 1
- 235000013878 L-cysteine Nutrition 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- 241000186673 Lactobacillus delbrueckii Species 0.000 description 1
- 241000194034 Lactococcus lactis subsp. cremoris Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241001468192 Leuconostoc citreum Species 0.000 description 1
- 241001468194 Leuconostoc mesenteroides subsp. dextranicum Species 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 241000202223 Oenococcus Species 0.000 description 1
- 241000191998 Pediococcus acidilactici Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 235000014962 Streptococcus cremoris Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- IOYNQIMAUDJVEI-BMVIKAAMSA-N Tepraloxydim Chemical group C1C(=O)C(C(=N/OC\C=C\Cl)/CC)=C(O)CC1C1CCOCC1 IOYNQIMAUDJVEI-BMVIKAAMSA-N 0.000 description 1
- 241000500334 Tetragenococcus Species 0.000 description 1
- 241000207194 Vagococcus Species 0.000 description 1
- 241000202221 Weissella Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229960004821 amikacin Drugs 0.000 description 1
- LKCWBDHBTVXHDL-RMDFUYIESA-N amikacin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O1)O)NC(=O)[C@@H](O)CCN)[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1O LKCWBDHBTVXHDL-RMDFUYIESA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229960005397 arbekacin Drugs 0.000 description 1
- MKKYBZZTJQGVCD-XTCKQBCOSA-N arbekacin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O1)O)NC(=O)[C@@H](O)CCN)[C@H]1O[C@H](CN)CC[C@H]1N MKKYBZZTJQGVCD-XTCKQBCOSA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 229960001192 bekanamycin Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 235000015155 buttermilk Nutrition 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 239000005549 deoxyribonucleoside Substances 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- VGONTNSXDCQUGY-UHFFFAOYSA-N desoxyinosine Natural products C1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 VGONTNSXDCQUGY-UHFFFAOYSA-N 0.000 description 1
- MXHRCPNRJAMMIM-UHFFFAOYSA-N desoxyuridine Natural products C1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-UHFFFAOYSA-N 0.000 description 1
- 229960003807 dibekacin Drugs 0.000 description 1
- JJCQSGDBDPYCEO-XVZSLQNASA-N dibekacin Chemical compound O1[C@H](CN)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N JJCQSGDBDPYCEO-XVZSLQNASA-N 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 229940032049 enterococcus faecalis Drugs 0.000 description 1
- 235000019225 fermented tea Nutrition 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 229940029575 guanosine Drugs 0.000 description 1
- 235000015220 hamburgers Nutrition 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 231100000206 health hazard Toxicity 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 229960003786 inosine Drugs 0.000 description 1
- 229930182824 kanamycin B Natural products 0.000 description 1
- SKKLOUVUUNMCJE-FQSMHNGLSA-N kanamycin B Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SKKLOUVUUNMCJE-FQSMHNGLSA-N 0.000 description 1
- SKKLOUVUUNMCJE-UHFFFAOYSA-N kanendomycin Natural products NC1C(O)C(O)C(CN)OC1OC1C(O)C(OC2C(C(N)C(O)C(CO)O2)O)C(N)CC1N SKKLOUVUUNMCJE-UHFFFAOYSA-N 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 229940004208 lactobacillus bulgaricus Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 description 1
- 229940061634 magnesium sulfate heptahydrate Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 150000004701 malic acid derivatives Chemical class 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012533 medium component Substances 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000006872 mrs medium Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 229940014662 pantothenate Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000001967 plate count agar Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 239000002342 ribonucleoside Substances 0.000 description 1
- 235000019992 sake Nutrition 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 235000020083 shōchū Nutrition 0.000 description 1
- 235000012046 side dish Nutrition 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 229960000707 tobramycin Drugs 0.000 description 1
- NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 description 1
- 239000007077 tomato juice medium Substances 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- YWYZEGXAUVWDED-UHFFFAOYSA-N triammonium citrate Chemical compound [NH4+].[NH4+].[NH4+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YWYZEGXAUVWDED-UHFFFAOYSA-N 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
- 229940045145 uridine Drugs 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
本発明は、検査用試料中の乳酸菌の有無を目視又は蛍光下で判定することができる乳酸菌検出用培地及びそれを用いた乳酸菌の検出方法に関する。 The present invention relates to a medium for detecting lactic acid bacteria capable of determining the presence or absence of lactic acid bacteria in a test sample visually or under fluorescence, and a method for detecting lactic acid bacteria using the same.
乳酸菌は、古くから味噌、醤油、清酒、ワイン、ヨーグルト、チーズ、乳酸菌飲料、漬物、発酵ソーセージ、発酵茶、馴れずしなどの多くの食品加工に利用されている。また、乳酸菌の保健的機能も解明され、プロバイオティック乳酸菌を利用した特定保健用食品は新たな食品市場を築きつつある。
ところが、食品加工分野を中心に、有用細菌として活用されている乳酸菌は、一方では酸味、酸臭、ネトの生成など、さまざまな変敗の原因となる。例えば、清酒製造での諸味が酸敗する腐造諸味や瓶詰製品が変敗する火落ち、また非加熱ビールの異味や濁り、あるいは水産練り製品や低塩化された漬物での酸敗などは、主に乳酸菌が原因となっている。ハム、ウインナーソーセージなどの食肉製品や惣菜、ハンバーグ、揚げ物などの加工食品などでも、加工段階や製品の品質異常に乳酸菌が関与している。
また、健康食品ブームを反映して、乳酸菌を用いる食品や飲料が多く製造されているため、製造ライン中にこのような乳酸菌が他の食品やアルコール飲料等に混入するおそれもある。
Lactic acid bacteria have long been used in many food processing such as miso, soy sauce, sake, wine, yogurt, cheese, lactic acid bacteria beverages, pickles, fermented sausages, fermented tea, and unfamiliar. In addition, the health function of lactic acid bacteria has been elucidated, and foods for specified health use using probiotic lactic acid bacteria are establishing a new food market.
However, lactic acid bacteria utilized as useful bacteria mainly in the food processing field, on the other hand, cause various deterioration such as acidity, acid odor, and production of neto. For example, roasted moromi in which the taste in sake brewing is soured, fires in which bottled products are spoiled, unpleasant taste and turbidity of unheated beer, acidity in fish paste products and low-salt pickles, etc. Is the cause. Lactic acid bacteria are involved in processing stages and product quality abnormalities in meat products such as ham and wiener sausages and processed foods such as side dishes, hamburgers and fried foods.
Moreover, since many foods and beverages using lactic acid bacteria are manufactured reflecting the health food boom, there is a possibility that such lactic acid bacteria may be mixed into other foods, alcoholic beverages, and the like during the production line.
乳酸菌が健康危害を起こすことはほとんどないが、乳酸菌による食品等の変敗等の発生は品質管理上好ましいものではなく早期に発見しないと経済的損失が大きく、その制御は食品加工メーカーにとっても重要な課題である。食肉製品に限らずさまざまな食品での乳酸菌による食品の品質異常を防ぐために、乳酸菌の排除を優先的に行うことは、結果として、多くの病原菌やその他有害細菌、また目的以外の細菌の排除にもつながる。また、このような場合の乳酸菌の検査は、メーカーにおける大量生産品の品質管理の一環であることから、操作が簡便であるだけでなく、結果が迅速に得られ、判定が容易である、ということが必要である。 Lactic acid bacteria rarely cause health hazards, but the deterioration of foods caused by lactic acid bacteria is not desirable for quality control, and if not discovered early, there is a large economic loss, and its control is important for food processing manufacturers. It is a difficult task. In order to prevent food quality abnormalities caused by lactic acid bacteria in various foods, not just meat products, priority is given to eliminating lactic acid bacteria, resulting in the elimination of many pathogenic bacteria, other harmful bacteria, and bacteria other than the intended ones. Is also connected. In addition, the inspection of lactic acid bacteria in such cases is part of the quality control of mass-produced products at the manufacturer, so that not only the operation is simple, but the results are obtained quickly and the judgment is easy. It is necessary.
これらのことから、従来以下の乳酸菌用検出培地が知られている。
(a)BCP加プレートカウント寒天培地
菌数測定用として公定法に記載されている(非特許文献1参照)。乳酸生成により酸性になるとBCPが紫から黄色に変化することを利用して、寒天培地に生育したコロニー周辺が黄色くなったコロニーを乳酸菌として測定する。
(b)MRS寒天培地、BL寒天培地
この2つの培地は、いずれも菌数測定法として公定法に記載されている(非特許文献1参照)。乳酸菌の生育に有効であるが、選択性はなく、乳酸菌以外の微生物も活発に生育する。
(c)APT寒天
乳酸菌用に開発された培地(非特許文献2参照)であり、グルコース10g/Lを含有する。
(d)APT寒天+BCP
APT寒天にpH指示薬であるBCPを添加した培地(非特許文献3参照)である。
(e)LBS寒天培地
乳酸桿菌の選択培地として開発され、以前から用いられていたトマトジュース培地より乳酸桿菌の選択性が高いと報告されている(非特許文献4参照)。寒天平板を二酸化炭素加環境において35℃で培養する。
From these facts, the following detection media for lactic acid bacteria are known.
(A) BCP-added plate count agar medium It is described in an official method for measuring the number of bacteria (see Non-Patent Document 1). Taking advantage of the fact that BCP changes from purple to yellow when it becomes acidic due to lactic acid production, colonies that grow yellow around the agar medium are measured as lactic acid bacteria.
(B) MRS agar medium, BL agar medium These two culture media are both described in the official method as a method for measuring the number of bacteria (see Non-Patent Document 1). Although effective for the growth of lactic acid bacteria, there is no selectivity, and microorganisms other than lactic acid bacteria grow actively.
(C) APT agar A medium developed for lactic acid bacteria (see Non-Patent Document 2), which contains glucose 10 g / L.
(D) APT agar + BCP
It is the culture medium (refer nonpatent literature 3) which added BCP which is a pH indicator to APT agar.
(E) LBS agar medium It has been reported that the selectivity of Lactobacillus is higher than the tomato juice medium that was developed as a selective medium for Lactobacillus and has been used before (see Non-Patent Document 4). Agar plates are cultured at 35 ° C. in a carbon dioxide atmosphere.
更に、乳酸菌用検出培地及びこれを用いた乳酸菌の検出方法として、例えば、pH6.2±0.2の乳酸菌用検出液体培地で培養し、培養液を除去して菌体を得、菌体を蛍光物質(アクリジンオレンジ−10−ドデシルブロミド)を添加し、蛍光強度により生菌数を測定する方法(特許文献1参照)や、Modified NBB培地等の既存培地にウイスキー蒸留残渣を含有させることによって、乳酸菌を迅速に増殖させる菌数計測用の培地(特許文献2参照)や、乳酸菌の増殖促進物質として、シチジン及びチミジン、麦芽汁発酵物が添加された、ビール醸造に有害なビール乳酸菌の検出・菌数測定用培地(特許文献3参照)が提案されている。 Furthermore, as a detection medium for lactic acid bacteria and a method for detecting lactic acid bacteria using the same, for example, culture is performed in a detection liquid medium for lactic acid bacteria having a pH of 6.2 ± 0.2, and the culture solution is removed to obtain bacterial cells. By adding a fluorescent substance (acridine orange-10-dodecyl bromide) and measuring the viable cell count by fluorescence intensity (see Patent Document 1), or by adding a whiskey distillation residue to an existing medium such as Modified NBB medium, Detection of beer lactic acid bacteria that are harmful to beer brewing, with the addition of cytidine, thymidine, and fermented wort as a growth-promoting substance for lactic acid bacteria (see Patent Document 2) A culture medium for bacterial count measurement (see Patent Document 3) has been proposed.
また、特定の乳酸菌を選択的に検出する培地及びこれを用いた乳酸菌の選択的な検出方法として、例えば、オリゴ糖に加えてプロピオン酸またはその塩を使用し、ビフィドバクテリウム菌と乳酸菌とを含有する物の中からビフィドバクテリウム菌を優先的に発育させ、その菌数を測定するための選択・生菌数測定用培地(特許文献4参照)や、寒天培地に生育促進剤として塩化リチウムおよびガラクトースを含有するビフィドバクテリア属に属する乳酸菌の選択的な検出および菌数計測用培地(特許文献5参照)や、オリゴ糖を含有するビフィドバクテリア属に属する乳酸菌を培養するための選択・生菌数測定用の寒天培地(特許文献6参照)や、pH指示薬を使用したビフィドバクテリア属に属する乳酸菌を培養するための液体の選択培地(特許文献7参照)が提案されている。 Further, as a selective detection method of a lactic acid bacterium using a medium that selectively detects a specific lactic acid bacterium, for example, propionic acid or a salt thereof is used in addition to oligosaccharide, and Bifidobacterium and lactic acid bacterium are used. As a growth promoter in a selective / viable cell count medium (see Patent Document 4) for preferential growth of Bifidobacteria from among the substances containing selenium and measuring the number of bacteria A medium for selective detection and bacterial count measurement of lactic acid bacteria belonging to the genus Bifidobacterium containing lithium chloride and galactose (see Patent Document 5), and for culturing lactic acid bacteria belonging to the genus Bifidobacterium containing oligosaccharides Agar medium for selection / viability count measurement (see Patent Document 6) and liquid selection medium for culturing lactic acid bacteria belonging to the genus Bifidobacterium using a pH indicator (Patent Document 7) Irradiation) has been proposed.
しかしながら、更なる、幅広い食品や飲料等の検査試料中の乳酸菌を的確に効率よく簡便に検出できる培地やこれを用いた検出方法が求められている。 However, there is a need for a medium that can accurately and easily detect lactic acid bacteria in a wide range of test samples such as foods and beverages, and a detection method using the medium.
本発明は、検査試料中の乳酸菌の有無を、的確に効率よく、しかも、一般的な食品や飲料、水などの検査や製造工程検査にも幅広く利用できる乳酸菌検出用培地及びこの培地を用いた乳酸菌検出方法を提供することに関する。 The present invention uses a lactic acid bacteria detection medium that can accurately and efficiently be used for the presence or absence of lactic acid bacteria in a test sample, and that can be widely used for inspection of general foods, beverages, water, etc. and manufacturing process inspections, and this medium. The present invention relates to providing a method for detecting lactic acid bacteria.
本発明者は、斯かる実情に鑑み、種々乳酸菌検出用培地を検討した結果、従来の培地では、乳酸菌以外の菌が生育したり、目視等での乳酸菌の判別が困難なことが多かったが、培地に、β-ガラクトシダーゼにより分解される酵素基質、乳酸菌以外の微生物発育阻止物質(特にアミノグリコシド系抗生物質)、及びpH5.0〜6.5にするpH調整剤の3成分を含有させることによって、食品や飲料等の被検体中に存在する乳酸菌が発育する段階で特異的に酵素(β-ガラクトシダーゼ)を産生し、これと酵素基質が反応して集落及びその周辺が着色するので乳酸菌の存在を迅速に簡便に確認することができ、かつ、アミノグリコシド系抗生物質等により、β-ガラクトシダーゼを産生する大腸菌群等の乳酸菌以外の微生物の発育を抑制することができるので、的確に効率よく乳酸菌を検出することができ、しかも、一般的な食品や飲料、水などの検査や製造工程検査にも幅広く利用できることを見出し、本発明を完成させるに至った。 As a result of studying various lactic acid bacteria detection media in view of such circumstances, the present inventor has often found that bacteria other than lactic acid bacteria grow or that it is difficult to visually distinguish lactic acid bacteria. By adding three components to the medium, an enzyme substrate that is degraded by β-galactosidase, a microbial growth inhibitor other than lactic acid bacteria (particularly aminoglycoside antibiotics), and a pH adjuster that adjusts the pH to 5.0 to 6.5. The presence of lactic acid bacteria because the enzyme (β-galactosidase) is specifically produced at the stage of growth of lactic acid bacteria present in food, beverages, and other specimens, and this reacts with the enzyme substrate to color the settlement and its surroundings. Can be confirmed quickly and easily, and aminoglycoside antibiotics can suppress the growth of microorganisms other than lactic acid bacteria such as coliforms that produce β-galactosidase. Since the kill, it can be detected accurately and efficiently lactic acid bacteria, moreover, common foods and beverages, found that it is also widely used in inspection and manufacturing process inspection, such as water, has led to the completion of the present invention.
すなわち、本発明は、β-ガラクトシダーゼにより分解される酵素基質、乳酸菌以外の微生物発育阻止物質、及びpH5.0〜6.5にするpH調整剤を含有する乳酸菌検出用培地を提供するものである。
また、本発明は、前記乳酸検出用培地に被検体を接種した後、培養し、集落の色を目視又は蛍光下で判定することを特徴とする乳酸菌の検出方法を提供するものである。
That is, the present invention provides a medium for detecting lactic acid bacteria comprising an enzyme substrate that is degraded by β-galactosidase, a microbial growth inhibitor other than lactic acid bacteria, and a pH adjuster that adjusts the pH to 5.0 to 6.5. .
In addition, the present invention provides a method for detecting lactic acid bacteria, which comprises inoculating a subject with the lactic acid detection medium and then culturing, and determining the color of the colony visually or under fluorescence.
本発明の乳酸菌検出培地及びこれを用いた乳酸菌の検出方法によれば、被検体中に乳酸菌が存在すると、乳酸菌を選択的に生育させ、目視又は蛍光下で認識できるように乳酸菌の集落が着色するので、乳酸菌の存在を的確に効率よく簡便に確認することができる。しかも、本発明は、種々の微生物が存在する一般的な食品や飲料、水などの検査や製造工程検査にも幅広く利用することができる。 According to the lactic acid bacteria detection medium of the present invention and the method for detecting lactic acid bacteria using the same, when lactic acid bacteria are present in the subject, the lactic acid bacteria are selectively grown and colored so that they can be recognized visually or under fluorescence. Therefore, the presence of lactic acid bacteria can be confirmed accurately, efficiently and simply. In addition, the present invention can be widely used for inspection of general foods, beverages, water, etc. in which various microorganisms exist and manufacturing process inspection.
本発明にて検出する対象の乳酸菌は、糖を発酵し、多量の乳酸を生産する細菌の総称である。この乳酸菌は、Lactobacillus属、Pediococcus属、Tetragenococcus属、Carnobacterium属、Vagococcus属、Leuconostoc属、Weissella属、Oenococcus属、Atopobium属、Streptococcus属、Enterococcus属、Lactococcus属、Enterococcus属、Bifidobacterium属等に分類され、約二百数十種の乳酸菌が報告されている。
このうち、Lactobacillus属(例えばLactobacillus acidophilus、Lactobacillus delbrueckii subsp. bulgaricus、Lactobacillus delbrueckii subsp. lactis、Lactobacillus brevis、Lactobacillus plantarum、Lactobacillus amylophilus、Lactobacillus animalis、Lactobacillus curvatus、Lactobacillus helveticus、Lactobacillus sakei、Lactobacillus fructivorans等);Streptococcus属(例えばStreptococcus thermophilus);Lactococcus属(例えば、Lactococcus lactis subsp. cremoris等);Enterococcus属(例えば、Enterococcus faecalis, Enterococcus faecium等);Pediococcus属(例えば、Pediococcus acidilactici, Pediococcus pentosaceus, Pediococcus damnosus等)、Leuconostoc属(例えば、Leuconostoc mesenteroides subsp. mesentedoides、Leuconostoc citreum、Leuconostoc mesenteroide subsp. dextranicum等);Bifidobacterium属(例えば、Bifidobacterium longum、Bifidobacterium pseudolongum, Bifidobacterium animalis, Bifidobacterium lactis, Bifidobacterium dentium等)が好ましい。このうち、Lactobacillus属及びLeuconostoc属がより好ましく、特にLactobacillus属が好ましい。
The target lactic acid bacteria to be detected in the present invention is a general term for bacteria that ferment sugar and produce a large amount of lactic acid. This lactic acid bacterium is classified into Lactobacillus genus, Pediococcus genus, Tetragenococcus genus, Carnobacterium genus, Vagococcus genus, Leuconostoc genus, Weissella genus, Oenococcus genus, Streptococcus genus, Enterococcus genus, Lactococcus genus, Enterococcus genus, Bifidobacterium genus, etc. About two hundred and ten types of lactic acid bacteria have been reported.
Among these, Lactobacillus genus (e.g. Lactobacillus acidophilus, Lactobacillus delbrueckii subsp.bulgaricus, Lactobacillus delbrueckii subsp. (Eg Streptococcus thermophilus); Lactococcus genus (eg Lactococcus lactis subsp. Cremoris etc.); Enterococcus genus (eg Enterococcus faecalis, Enterococcus faecium etc); Pediococcus genus (eg Pediococcus acidilactici, Pediococcus pencoscus (For example, Leuconostoc mesenteroides subsp. Mesentedoides, Leuconostoc citreum, Leuconostoc mesenteroide subsp. Dextranicum, etc.); entium etc.) is preferred. Among these, the genus Lactobacillus and the genus Leuconostoc are more preferable, and the genus Lactobacillus is particularly preferable.
本発明の培地に用いるβ-ガラクトシダーゼにより分解される酵素基質は、乳酸菌が発育する段階で特異的に産生する酵素(β-ガラクトシダーゼ)と反応して目視又は蛍光存在下で認識できる発色物質(色原体化合物及び蛍光性化合物等)が生成される発色酵素基質であれば特に限定されるものではない。この発色酵素基質としては、5−ブロモ−4−クロロ−3−インドリル−β−D−ガラクトピラノシド(「X−β−Gal」又は「X−β−gal」とも云う、青)、5−ブロモ−6−クロロ−3−インドキシル−β−D−ガラクトピラノシド(MAGENTA−β−ガラクトピラノシド、赤紫)、5−ブロモ−6−クロロ−3−インドリル−β−D−ガラクトピラノシド(赤紫)、6−クロロ−3−インドリル−β−D−ガラクトピラノシド(ピンク)及びオルトニトロフェニル−β−D−ガラクトピラノシド(「ONPG」とも云う、黄)等から選ばれる1種以上のものが挙げられ、特に発色した集落を簡単に認識することができるX−β−Galが好ましい。
培地中の酵素基質の含有量は、特に限定されないが、培地中、0.015〜1.5質量%であるのが好ましい。
The enzyme substrate decomposed by β-galactosidase used in the medium of the present invention is a coloring substance (color) that reacts with an enzyme (β-galactosidase) specifically produced at the stage where lactic acid bacteria develop and can be recognized visually or in the presence of fluorescence. There is no particular limitation as long as it is a chromogenic enzyme substrate from which a base compound and a fluorescent compound are produced. As the chromogenic enzyme substrate, 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (also referred to as “X-β-Gal” or “X-β-gal”, blue), 5 -Bromo-6-chloro-3-indoxyl-β-D-galactopyranoside (MAGENTA-β-galactopyranoside, magenta), 5-bromo-6-chloro-3-indolyl-β-D- Galactopyranoside (red purple), 6-chloro-3-indolyl-β-D-galactopyranoside (pink) and orthonitrophenyl-β-D-galactopyranoside (also referred to as “ONPG”, yellow) One or more selected from the above are mentioned, and X-β-Gal that can easily recognize a colored colony is particularly preferable.
The content of the enzyme substrate in the medium is not particularly limited, but is preferably 0.015 to 1.5% by mass in the medium.
本発明の培地に用いる乳酸菌以外の微生物(以下、「他の微生物」とも云う)発育阻止物質は、乳酸菌に対する発育阻害作用は弱く、他の微生物に対する発育阻害作用があるものが好ましく、培地中の発育阻止物質の含有量を調整することによってこれら微生物の発育を調整できるものが望ましい。
この発育阻止物質としては、例えば、アミノグリコシド系抗生物質(例えば、カナマイシン、ベカナマイシン等のカナマイシン系;ストレプトマイシン;ゲンタマイシン;トブラマイシン;アミカシン;ジベカシン;アルベカシン)等が挙げられる。
アミノグリコシド系抗生物質の中でも、特にカナマイシン系抗生物質が、X−β−Gal等を分解する大腸菌群の生育を阻害しつつ、乳酸菌の生育を阻害し難い点から、好ましい。
乳酸菌以外の微生物発育阻止物質の含有量は、培地中、0.001〜0.2質量%、より0.001〜0.04質量%、更に0.003〜0.02質量%、より更に0.004〜0.0095質量%、殊更に0.0045〜0.009質量%であるのが好ましく、特に、0.005〜0.009質量%であるのが、他の微生物の生育を阻害しつつ、乳酸菌が生育できるので、好ましい。Lactobacillus属を選択的に検出する場合には、Lactobacillus属はカナマイシン系抗生物質による発育阻害作用が少ないので、培地中、0.0045〜0.04質量%であるのが好ましい。
The microorganisms other than lactic acid bacteria (hereinafter, also referred to as “other microorganisms”) used in the culture medium of the present invention have a weak growth inhibitory action against lactic acid bacteria, and preferably have a growth inhibitory action against other microorganisms. What can adjust the growth of these microorganisms by adjusting the content of the growth inhibitory substance is desirable.
Examples of the growth inhibitor include aminoglycoside antibiotics (for example, kanamycins such as kanamycin and bekanamycin; streptomycin; gentamicin; tobramycin; amikacin; dibekacin; arbekacin) and the like.
Among the aminoglycoside antibiotics, kanamycin antibiotics are particularly preferable because they inhibit the growth of coliforms that decompose X-β-Gal and the like and hardly inhibit the growth of lactic acid bacteria.
The content of the microbial growth inhibitor other than lactic acid bacteria is 0.001 to 0.2% by mass, more 0.001 to 0.04% by mass, further 0.003 to 0.02% by mass, and even more 0 in the medium. It is preferably 0.004 to 0.0095% by mass, more preferably 0.0045 to 0.009% by mass, and especially 0.005 to 0.009% by mass inhibits the growth of other microorganisms. However, it is preferable because lactic acid bacteria can grow. In the case of selectively detecting the genus Lactobacillus, the genus Lactobacillus has a small inhibitory effect on growth by kanamycin antibiotics, and is preferably 0.0045 to 0.04% by mass in the medium.
本発明の培地に用いられるpH調整剤は、乳酸菌を接種する際の培地のpHを5.0〜6.5、より5.0〜6.2になるように調整できるものが好ましく、特に、5.0〜5.9とするもののが、上記発育阻害物質との併用によって、乳酸菌が良好に生育すると共に、多くの他の微生物(特に大腸菌群)の発育を阻害することができ、乳酸菌の検出が容易となるので、好ましい。このpH調整剤に用いる成分としては、例えば、しゅう酸、酢酸、フマル酸、リンゴ酸、乳酸、グルコン酸、酒石酸等の有機酸塩、炭酸ナトリウム、炭酸水素ナトリウム等の炭酸塩、リン酸、塩酸、硫酸等の無機塩、水酸化ナトリウム等の水酸化物、アンモニア又はアンモニア水、クエン酸アミン類、低級アルカノールアミン類、アルギニン、リジン等の塩基性アミノ酸等から選ばれる1種以上のものが挙げられる。 The pH adjuster used in the medium of the present invention is preferably one that can adjust the pH of the medium at the time of inoculation with lactic acid bacteria to 5.0 to 6.5, more preferably 5.0 to 6.2, Although 5.0 to 5.9 can be used together with the growth inhibitory substance, the lactic acid bacteria can grow well and can inhibit the growth of many other microorganisms (particularly coliforms). This is preferable because it facilitates detection. Examples of components used in the pH adjuster include organic acid salts such as oxalic acid, acetic acid, fumaric acid, malic acid, lactic acid, gluconic acid, and tartaric acid, carbonates such as sodium carbonate and sodium hydrogen carbonate, phosphoric acid, hydrochloric acid, and the like. One or more selected from inorganic salts such as sulfuric acid, hydroxides such as sodium hydroxide, ammonia or aqueous ammonia, citrate amines, lower alkanolamines, basic amino acids such as arginine and lysine It is done.
本発明の培地は、上記必須成分の他、炭素源、窒素源、ミネラル、ビタミン類等の任意成分を配合し、一般的な製造方法によって得ることができる。
例えば、炭素源としては、フルクトース、ラクトース、サッカロース等から選ばれる1種以上のもの;窒素源としては、タンパク質分解物、酵母エキス、魚肉エキス等から選ばれる1種以上のもの:このミネラル源としては、銅、亜鉛、マグネシウム、コバルト等から選ばれる1種以上のもの:ビタミン類としては、ニコチン酸、パントテネート、ビオチン、リボフラビン、葉酸等から選ばれる1種以上のものが挙げられる。
これら炭素源等を含有する基礎培地としては、公知の乳酸菌検出用基礎培地でもよく、例えば特許文献1〜5に記載のようなMRS培地、BL培地、APT培地、APT+BCP培地及びLBS培地等が挙げられ、これらの培地組成を適宜変更してもよい。
The medium of the present invention can be obtained by a general production method by blending optional components such as a carbon source, a nitrogen source, minerals and vitamins in addition to the above essential components.
For example, the carbon source is one or more selected from fructose, lactose, saccharose, etc .; the nitrogen source is one or more selected from proteolysate, yeast extract, fish extract, etc .: As this mineral source Is one or more selected from copper, zinc, magnesium, cobalt and the like: Examples of vitamins include one or more selected from nicotinic acid, pantothenate, biotin, riboflavin, folic acid and the like.
The basal medium containing these carbon sources may be a known basal medium for detecting lactic acid bacteria, such as MRS medium, BL medium, APT medium, APT + BCP medium, and LBS medium as described in Patent Documents 1 to 5. These medium compositions may be changed as appropriate.
また、上記基礎培地に、乳酸菌増殖促進成分を含有させることが好ましい。
この乳酸菌増殖促進成分としては、大麦焼酎蒸留残液(特許第3527661号公報参照)、カルシウム塩(特許第2673333号公報参照)、バターミルク(特開2000−102380号公報参照)、ウイスキー蒸留残渣(特開平03−91493号公報参照)、シチジン及びチミジン、麦芽汁発酵物(特開平03−130071号公報参照)、酒かす抽出物(特開平3−172171号公報参照)、クエン酸塩又はリンゴ酸塩(特開昭57−102184号公報参照)、L-システイン(特開昭54−143585号公報参照)、遊離塩基(アデニン、シトシン、グアニン、チミン、ウラシル及びイノシン)、リボヌクレオシド(アデノシン、シチジン、グアノシン、ウリジン)及びデオキシリボヌクレオシド(2′−デオキシアデノシン、2′−デオキシシチジン、2′−デオキシグアノシン、2′−デオキシウリジン及びチミジン)(特開2000−279166号公報参照)や、Gal−(Gal)n−Glc(n=1〜4)のオリゴ糖、プロピオン酸又はその塩(特開平11−28098号公報、特開平4−20283号公報参照)、塩化リチウム及びガラクトース(特開平6−343491号公報参照)等から選ばれる1種以上のものが挙げられる。
The basal medium preferably contains a lactic acid bacteria growth promoting component.
As this lactic acid bacteria growth promoting component, barley shochu distillation residue (see Japanese Patent No. 3527661), calcium salt (see Japanese Patent No. 2673333), buttermilk (see Japanese Patent Laid-Open No. 2000-102380), whiskey distillation residue (see JP-A-03-91493), cytidine and thymidine, fermented wort (see JP-A-03-130071), sake lees extract (see JP-A-3-172171), citrate or malic acid Salt (see JP-A-57-102184), L-cysteine (see JP-A-54-143585), free base (adenine, cytosine, guanine, thymine, uracil and inosine), ribonucleoside (adenosine, cytidine) , Guanosine, uridine) and deoxyribonucleoside (2'-deoxyadenosine, 2'-deoxysi) Gin, 2′-deoxyguanosine, 2′-deoxyuridine and thymidine) (see JP 2000-279166), Gal- (Gal) n-Glc (n = 1 to 4) oligosaccharides, propionic acid or Examples thereof include one or more selected from salts thereof (see JP-A-11-28098 and JP-A-4-20283), lithium chloride and galactose (see JP-A-6-343491).
更に、本発明の培地に、固体又は半固体培地にするため、ゼラチン、寒天、カラギーナン等の固体化成分を含有させてもよい。
また、本発明の培地に、液体培地を吸収させる、繊維質吸水性シート等の繊維質液体吸収素材を使用してもよい。繊維としては、例えば、植物、動物等由来の天然繊維、化学合成、ガラス繊維等由来の化学繊維等が挙げられ、また繊維をシート状にした不織布が好ましい。
Further, the medium of the present invention may contain solidifying components such as gelatin, agar, and carrageenan in order to obtain a solid or semi-solid medium.
Moreover, you may use fibrous liquid absorption raw materials, such as a fibrous water absorbing sheet, which make a culture medium of this invention absorb a liquid culture medium. Examples of the fibers include natural fibers derived from plants, animals and the like, chemical fibers derived from chemical synthesis, glass fibers, and the like, and nonwoven fabrics in which the fibers are formed into a sheet shape are preferable.
本発明の培地の作製方法としては、例えば、上記各培地組成成分に精製水等を添加し混合攪拌した後、オートクレーブ等で滅菌し、これを滅菌シャーレ等に分注し、冷却又は放冷する方法;上記各培地成分にエタノールや精製水等を添加し混合攪拌した後、繊維質液体吸収素材を収納した容器に分注し、ガンマ線照射滅菌する方法等が挙げられる。 As a method for preparing the culture medium of the present invention, for example, after adding purified water or the like to each of the above-mentioned medium composition components, mixing and stirring, sterilizing with an autoclave or the like, dispensing this into a sterilized petri dish, etc., and cooling or allowing to cool Method: A method in which ethanol, purified water, or the like is added to each medium component described above, mixed and stirred, and then dispensed into a container containing a fibrous liquid absorbent material, followed by sterilization by gamma irradiation.
本発明の乳酸菌の検出方法は、上記で得られた乳酸菌検出用培地に、被検体を接種した後、所定の条件にて培養し、形成された集落の色を、目視又は蛍光存在下で確認し、乳酸菌の存在の有無を判定する。 In the method for detecting lactic acid bacteria of the present invention, the lactic acid bacteria detection medium obtained above is inoculated with a subject, cultured under predetermined conditions, and the color of the formed colony is confirmed visually or in the presence of fluorescence. Then, the presence or absence of lactic acid bacteria is determined.
被検体としては、特に限定されないが、食品、飲料、河川、海水等の検査用試料が挙げられる。この検査用試料は、そのまま又はこれを濃縮或いは希釈して本発明の培地に接種して培養してもよい。このとき、接種の際、検査用試料を、10-2〜10-10倍程度の希釈するのが、集落数測定の点から好ましい。
また、接種法は、特に限定されないが、平板塗抹法、画線塗抹法が、好ましい。
Although it does not specifically limit as a test object, Test samples, such as a foodstuff, a drink, a river, seawater, are mentioned. This test sample may be cultivated as it is or after concentrating or diluting it and inoculating the medium of the present invention. At this time, it is preferable to dilute the test sample about 10 −2 to 10 −10 times at the time of inoculation from the viewpoint of the number of settlements.
Further, the inoculation method is not particularly limited, but a flat plate smearing method and an image smearing method are preferable.
培養条件は、嫌気培養、好気培養又は炭酸ガス培養の何れでもよく、このときの雰囲気は、空気、窒素ガス、アルゴンガス、ヘリウムガス、炭酸ガスの何れでもよい。このうち、乳酸菌発育の点から、特に、炭酸ガスの雰囲気下による炭酸ガス培養が好ましい。
また、培養温度は、特に限定されないが、乳酸菌の生育に適した温度である25〜42℃、特に30〜40℃が好ましい。
また、培養日数は、特に限定されないが、24〜96時間、特に40〜72時間であるのが好ましい。
The culture conditions may be any of anaerobic culture, aerobic culture, or carbon dioxide gas culture, and the atmosphere at this time may be any of air, nitrogen gas, argon gas, helium gas, and carbon dioxide gas. Among these, from the viewpoint of growth of lactic acid bacteria, carbon dioxide gas culture under an atmosphere of carbon dioxide gas is particularly preferable.
Moreover, although culture | cultivation temperature is not specifically limited, 25-42 degreeC which is the temperature suitable for growth of lactic acid bacteria, especially 30-40 degreeC is preferable.
The number of days for cultivation is not particularly limited, but is preferably 24 to 96 hours, particularly 40 to 72 hours.
培地中に形成された乳酸菌の集落(その周辺も含む)の色は、用いる発色酵素基質によって異なるが、X−β−Galの場合には、薄青〜青、青緑の色調であり、ONPGの場合には、黄の色調であり、斯かる色調の存在によって乳酸菌の集落であると判別する一方で、斯かる色調の存在が認められない場合には、乳酸菌の集落ではないと判別する。このようにして、検体中の乳酸菌の存在の有無や集落数を判定する。
ここで、蛍光下とは、蛍光灯の照射下での目視を含む意味であるが、例えばX−β−Galの場合の特定の波長(380〜570nm)で検出(吸光度測定)を行なってもよい。吸光度測定の場合には、菌体数と吸光度が比例するので、吸光度が高いほど乳酸菌は多く存在すると判定したり、標準物と比較して、乳酸菌の存在量を定量してもよい。一方、吸光度がコントロール(被検体無添加)と比較してほとんど同じ場合には乳酸菌が存在しないと判定してもよい。
The color of the lactic acid bacteria colonies (including their surroundings) formed in the medium varies depending on the chromogenic enzyme substrate to be used. In the case of X-β-Gal, the color tone is light blue to blue and blue-green. In this case, the color tone of yellow is determined to be a colony of lactic acid bacteria based on the presence of such a color tone. On the other hand, if the color tone is not found, it is determined not to be a colony of lactic acid bacteria. In this way, the presence or absence of lactic acid bacteria in the sample and the number of settlements are determined.
Here, under fluorescence is meant to include visual observation under illumination of a fluorescent lamp. For example, even when detection (absorbance measurement) is performed at a specific wavelength (380 to 570 nm) in the case of X-β-Gal. Good. In the case of absorbance measurement, since the number of bacterial cells and the absorbance are proportional, it may be determined that the higher the absorbance, the more lactic acid bacteria are present, or the amount of lactic acid bacteria present may be quantified in comparison with a standard. On the other hand, if the absorbance is almost the same as that of the control (no subject added), it may be determined that lactic acid bacteria are not present.
以下に実施例を挙げて本発明を具体的に説明するが、本発明はこれら実施例に限定されるものではない。 EXAMPLES The present invention will be specifically described below with reference to examples, but the present invention is not limited to these examples.
実施例1
MRS寒天培地(Difco)(pH6.5)を調製後、これに、X-β‐gal(Biosynth)を培地中0.15質量%になるように添加し、試験培地とした。
血液寒天培地(トリプトソーヤ寒天培地(日水製薬)を基礎培地とし、馬脱繊維血液(コージンバイオ)を5%添加)を調製後、X-β‐galを添加しないものを、「血液寒天」として用いた。
これに表1に示すような20種の乳酸菌を接種し、37℃又は25℃で48時間、好気培養(酸素約21%、窒素約78%の雰囲気下)又は嫌気培養(水素5%、二酸化炭素10%及び窒素85%の雰囲気下)を行い、このとき形成されたコロニーの色及びコロニー径(mm)を測定した。その結果を表1に示した。
表1に示すように、試験培地において、多くの乳酸菌で青色の集落を形成することが認められ、β−ガラクトシダーゼにより分解される酵素基質を用いることで、種々の乳酸菌を検出することができることが認められた。
Example 1
After preparing an MRS agar medium (Difco) (pH 6.5), X-β-gal (Biosynth) was added to the medium so as to be 0.15% by mass to obtain a test medium.
After preparing a blood agar medium (tryptosoya agar medium (Nissui Pharmaceutical) as a basic medium and 5% horse defibrillated blood (Kohjin Bio) added), the one without X-β-gal is called “blood agar” Using.
20 kinds of lactic acid bacteria as shown in Table 1 were inoculated into this, and aerobic culture (in an atmosphere of about 21% oxygen and about 78% nitrogen) or anaerobic culture (5% hydrogen, 37 ° C or 25 ° C) Under an atmosphere of 10% carbon dioxide and 85% nitrogen), the color and colony diameter (mm) of the colonies formed at this time were measured. The results are shown in Table 1.
As shown in Table 1, it is recognized that many lactic acid bacteria form blue colonies in the test medium, and various lactic acid bacteria can be detected by using an enzyme substrate that is degraded by β-galactosidase. Admitted.
実施例2
MRS寒天培地(Difco)(pH6.5)を調製後、これに、X-β‐gal(Biosynth)を培地中 0.15質量%になるように添加し、またカナマイシン0-100mg/mlを、培地中、0〜0.15質量%(0.15、0.075、0.0375、0.0188、0.0094、0.0047、0質量%)になるように添加し、試験培地とした。
血液寒天培地(トリプトソーヤ寒天培地(日水製薬)を基礎培地とし、馬脱繊維血液を5%添加)を調製後、X-β‐gal及びカナマイシンを添加しないものを、「血液寒天」として用いた。
これに表2に示すような11種の乳酸菌および、6種の乳酸菌以外の菌株をミクロプランター(小高秀正ら、日本臨床微生物学雑誌 J. Jpn. Soc. Clin. Microbiol., 10(1), 6-17, 2000)で接種し、48時間、好気培養(酸素約21%、窒素約78%の雰囲気下)を行い、その発育を判定した。その結果を表2に示した。
表2に示すように、培地中で一定濃度(特に0.0047質量%)以上のカナマイシン濃度にすると、乳酸菌は生育するものの、乳酸菌以外の菌(特に大腸菌群であるE.coliおよびEnterobacter sp.)の発育を抑制することができ、特にLactobacillus属では、培地中のカナマイシンが高濃度でも発育が認められた。
Example 2
After preparing MRS agar medium (Difco) (pH 6.5), X-β-gal (Biosynth) was added to the medium so as to be 0.15% by mass, and kanamycin 0-100 mg / ml was added in the medium. , 0 to 0.15 mass% (0.15, 0.075, 0.0375, 0.0188, 0.0094, 0.0047, 0 mass%) to obtain a test medium.
After preparing a blood agar medium (tryptosoya agar medium (Nissui Pharmaceutical) as a basic medium and 5% horse defibrinated blood added), the one without X-β-gal and kanamycin was used as “blood agar” .
11 types of lactic acid bacteria as shown in Table 2 and strains other than 6 types of lactic acid bacteria were identified as microplanters (Hidemasa Odaka et al., J. Jpn. Soc. Clin. Microbiol., 10 (1), 6-17, 2000), and aerobic culture (in an atmosphere of about 21% oxygen and about 78% nitrogen) was performed for 48 hours, and its growth was judged. The results are shown in Table 2.
As shown in Table 2, when the concentration of kanamycin is higher than a certain concentration (especially 0.0047% by mass) in the medium, lactic acid bacteria grow, but bacteria other than lactic acid bacteria (especially E. coli and Enterobacter sp.) Growth can be suppressed. In particular, in the genus Lactobacillus, growth was observed even when the concentration of kanamycin in the medium was high.
実施例3
MRS寒天培地(Difco)(pH6.5)を調製後、これに、X-β‐gal(Biosynth)を培地中 0.15質量%になるように添加し、またカナマイシンを培地中、0.0086質量%になるように添加し、「本培地」とした。
MRS寒天培地に、上述と同様にX-β−gal添加し、カナマイシンを添加しなかったものを「参考培地」とし、血液寒天培地(トリプトソーヤ寒天培地(日水製薬)を基礎培地とし、馬脱繊維血液を5%添加)を調製後、X-β‐galを添加しないものを、「血液寒天」として用いた。
これに表3に示す4種の乳酸菌及び4種の大腸菌群をミスラ法(文献;MILESA, . A,et al., 1938. J. Hyg., C u d. , 38, p732.)で接種し、35℃にて48時間、炭酸ガス培養を行い、コロニー数、色およびコロニー径(mm)を測定した。その結果を表3に示した。
表3に示すように、培地中、カナマイシン濃度0.0086質量%を添加することによって、乳酸菌の発育は抑制されず、大腸菌群等の乳酸菌以外の菌の発育が抑制されることが認められた。
Example 3
After preparing MRS agar medium (Difco) (pH 6.5), X-β-gal (Biosynth) is added to the medium so as to be 0.15% by mass, and kanamycin is 0.0086% by mass in the medium. As described above, this was used as “main medium”.
In the same manner as above, X-β-gal was added to the MRS agar medium, but kanamycin was not added as the “reference medium”. The blood agar medium (tryptosoya agar medium (Nissui Pharmaceutical) was used as the basic medium) After preparation of fiber blood (5% added), the product without X-β-gal was used as “blood agar”.
4 kinds of lactic acid bacteria and 4 kinds of coliform bacteria shown in Table 3 were inoculated by the MISULA method (literature; MILESA,. A, et al., 1938. J. Hyg., Cu d., 38, p732.) Then, carbon dioxide gas culture was performed at 35 ° C. for 48 hours, and the number of colonies, color, and colony diameter (mm) were measured. The results are shown in Table 3.
As shown in Table 3, it was confirmed that by adding a kanamycin concentration of 0.0086% by mass in the medium, the growth of lactic acid bacteria was not suppressed, and the growth of bacteria other than lactic acid bacteria such as coliforms was suppressed.
実施例4
培地組成成分としてペプトン 10g、肉エキス 10g、酵母エキス 5g、ブドウ糖20gクエン酸アンモニウム 2g、酢酸ナトリウム 5g、硫酸マグネシウム七水和物 0.1g、硫酸マンガン 0.05g、リン酸水素二カリウム 2g、キサンタンガム 30g、及びX-β-gal 0.1g、カナマイシン 6mgをヒドロキシプロピルセルロース1gを含有するエタノール 1000mlに加え、懸濁液とした。このエタノール懸濁液を1mlずつ綿状のシート(50φmm)を収納した容器(50φmm)に分注した後、乾燥させ、蓋をして簡易培地を作製した。本培地を乾燥剤とともにアルミ包材に密封包装した後、表面線量10〜20kGyのガンマ線照射を行って滅菌した。実施例3と同様の4種の乳酸菌及び4種の大腸菌群の菌液を作製し、1mlずつをこの簡易培地(pH6.5、当該培地中、X-β−Gal 0.15質量%、カナマイシン0.0086質量%)に接種し、37℃にて48時間炭酸ガス培養(5%二酸化炭素、15%酸素、窒素80%雰囲気下)を行い、菌数および色を測定した。その結果を表4に示した。
表4に示すように、簡易培地においても、X-β-galにより、多くの乳酸菌が青色の集落を形成すること、およびカナマイシンにより乳酸菌の発育に影響はなく、大腸菌群等の乳酸菌以外の菌の発育が抑制されることが認められた。
Example 4
Peptone 10g, meat extract 10g, yeast extract 5g, glucose 20g ammonium citrate 2g, sodium acetate 5g, magnesium sulfate heptahydrate 0.1g, manganese sulfate 0.05g, dipotassium hydrogen phosphate 2g, xanthan gum 30g, X-β-gal 0.1 g and kanamycin 6 mg were added to 1000 ml of ethanol containing 1 g of hydroxypropylcellulose to prepare a suspension. 1 ml of this ethanol suspension was dispensed into a container (50 mm) containing a cotton-like sheet (50 mm), and then dried and capped to prepare a simple medium. The medium was hermetically packaged in an aluminum wrapping material with a desiccant, and then sterilized by gamma irradiation with a surface dose of 10 to 20 kGy. Four types of lactic acid bacteria and four types of coliform bacteria were prepared in the same manner as in Example 3, and 1 ml each of this simple medium (pH 6.5, X-β-Gal 0.15 mass%, kanamycin 0.0086 mass in the medium). %), Followed by carbon dioxide culture at 37 ° C. for 48 hours (5% carbon dioxide, 15% oxygen, nitrogen 80% atmosphere), and the number of bacteria and color were measured. The results are shown in Table 4.
As shown in Table 4, even in a simple medium, many lactic acid bacteria form blue colonies with X-β-gal, and kanamycin has no effect on the growth of lactic acid bacteria. It was observed that the growth of
実施例5
MRS寒天培地(Difco)を調製後、これに、X-β‐gal(biosynth)を培地中0.01質量%(0.1g/L)になるように添加し、またカナマイシンを培地中、6×10-3質量%になるように添加し、さらにしゅう酸および炭酸ナトリウムを培地中pHが5.0、5.7、6.4、6.8、7.0、7.2になるように添加し、試験培地とした。
MRS寒天培地(Difco)(pH6.5)を調整後、X-β‐gal及びカナマイシンを添加しないものを、「参考培地」として用いた。
血液寒天培地(トリプトソーヤ寒天培地(日水製薬)を基礎培地とし、馬脱繊維血液(コージンバイオ)を5%添加 )を調製後、X-β‐gal及びカナマイシンを添加しないものを、「血液寒天」として用いた。
これに19種の乳酸菌及び80種の乳酸菌以外の菌株をミクロプランターで接種し、37℃にて48時間、炭酸ガス培養(5%二酸化炭素、15%酸素、窒素80%)を行い、その発育を測定した。その結果を表5に示した。
表5に示すように、微生物発育阻害物質(培地中、0.006質量%)を含有している、pH5.0〜6.4の培地において、乳酸菌以外の菌(特に大腸菌群)に対する選択性が強くなることが認められた。
Example 5
After preparing MRS agar medium (Difco), X-β-gal (biosynth) was added to 0.01 mass% (0.1 g / L) in the medium, and kanamycin was added in the medium at 6 × 10 − 3 % by mass was added, and oxalic acid and sodium carbonate were further added so that the pH in the medium was 5.0, 5.7, 6.4, 6.8, 7.0, 7.2, and used as a test medium.
After adjusting the MRS agar medium (Difco) (pH 6.5), a medium to which X-β-gal and kanamycin were not added was used as a “reference medium”.
After preparing a blood agar medium (tryptosoya agar medium (Nissui Pharmaceutical) as a basic medium, 5% horse defibrinated blood (Kohjin Bio) added), the one without X-β-gal and kanamycin is added. Was used.
This strain was inoculated with 19 types of lactic acid bacteria and strains other than 80 types of lactic acid bacteria using a microplanter, and cultured at 37 ° C for 48 hours with carbon dioxide gas (5% carbon dioxide, 15% oxygen, nitrogen 80%). Was measured. The results are shown in Table 5.
As shown in Table 5, the selectivity to bacteria other than lactic acid bacteria (especially coliforms) is strong in a medium of pH 5.0 to 6.4 containing a microbial growth inhibitor (0.006% by mass in the medium). Was recognized.
実施例6
「pH6.4」とした以外は、上記実施例5と同様にして、Leuconostoc dextranicum JCM9700、Streptococcus thermophilus ATCC14485、Bifidobacterium pseudolongum JCM1205について、発育を測定した。それぞれ、「+」「+」「W」と生育が認められた。
Example 6
The growth of Leuconostoc dextranicum JCM9700, Streptococcus thermophilus ATCC14485, and Bifidobacterium pseudolongum JCM1205 was measured in the same manner as in Example 5 except that “pH 6.4” was used. Growth was recognized as “+”, “+”, and “W”, respectively.
実施例7
「pH」を「pH6.4」と、および、「カナマイシン」を「ゲンタマイシン」とした以外は、上記実施例5と同様にして、乳酸菌Lactobacillus acidophilus ATCC19992、Lactobacillus bulgaricus ATCC11842および大腸菌群Escherichia coli ATCC8739、Enterobacter sp.CCJC13024について発育を測定した。乳酸菌に関してはそれぞれ「+」、「+」と発育が認められ、大腸菌群に関してはそれぞれ「−」、「−」と発育が認められなかった。
Example 7
The lactic acid bacteria Lactobacillus acidophilus ATCC19992, Lactobacillus bulgaricus ATCC11842 and Escherichia coli ATCC8739, Enterobacter are the same as in Example 5 except that “pH” is “pH6.4” and “kanamycin” is “gentamicin”. Growth was measured for sp.CCJC13024. Growth was recognized as “+” and “+” for lactic acid bacteria, respectively, and growth was not recognized as “−” and “−” for coliforms, respectively.
従って、本発明の乳酸菌検出方法および乳酸菌検出用培地を使用すると、多くの乳酸菌において、乳酸菌の産生した酵素(β-ガラクトシダーゼ)が存在する範囲が全て着色し、乳酸菌のコロニーが明瞭になり、また同様に着色する大腸菌群の発育を抗生物質により抑制することができ、的確に効率よく検査用試料中の乳酸菌の有無を目視又は蛍光下で判定することが可能であることを明らかにした。 Therefore, when the method for detecting lactic acid bacteria and the culture medium for detecting lactic acid bacteria of the present invention are used, in many lactic acid bacteria, the entire range where the enzyme (β-galactosidase) produced by lactic acid bacteria is colored, and colonies of lactic acid bacteria become clear, Similarly, it has been clarified that the growth of the coliform group to be colored can be suppressed by antibiotics, and the presence or absence of lactic acid bacteria in the test sample can be accurately and efficiently determined visually or under fluorescence.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009145278A JP5519960B2 (en) | 2009-06-18 | 2009-06-18 | Lactic acid bacteria detection medium and detection method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009145278A JP5519960B2 (en) | 2009-06-18 | 2009-06-18 | Lactic acid bacteria detection medium and detection method |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2011000045A true JP2011000045A (en) | 2011-01-06 |
JP5519960B2 JP5519960B2 (en) | 2014-06-11 |
Family
ID=43558540
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009145278A Active JP5519960B2 (en) | 2009-06-18 | 2009-06-18 | Lactic acid bacteria detection medium and detection method |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5519960B2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016540513A (en) * | 2013-12-16 | 2016-12-28 | コンパニー ジェルヴェ ダノンCompagnie Gervais Danone | Method for differential enumeration of lactic acid bacteria in mixtures in food |
JP2017137199A (en) * | 2016-02-01 | 2017-08-10 | 国立大学法人 宮崎大学 | Ceramic porous body for lactic acid bacterium pickle, and manufacturing method thereof |
JP2018518158A (en) * | 2015-04-29 | 2018-07-12 | スリーエム イノベイティブ プロパティズ カンパニー | Anaerobic microorganism culture device |
-
2009
- 2009-06-18 JP JP2009145278A patent/JP5519960B2/en active Active
Non-Patent Citations (2)
Title |
---|
JPN6014000183; Journal of applied bacteriology. 1994, Vol.77, No.1, p.42-48 * |
JPN6014000186; Infectious diseases in obstetrics and gynecology. 2006, Vol.2006, Article ID.18182, p.1-6 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016540513A (en) * | 2013-12-16 | 2016-12-28 | コンパニー ジェルヴェ ダノンCompagnie Gervais Danone | Method for differential enumeration of lactic acid bacteria in mixtures in food |
JP2018518158A (en) * | 2015-04-29 | 2018-07-12 | スリーエム イノベイティブ プロパティズ カンパニー | Anaerobic microorganism culture device |
JP2017137199A (en) * | 2016-02-01 | 2017-08-10 | 国立大学法人 宮崎大学 | Ceramic porous body for lactic acid bacterium pickle, and manufacturing method thereof |
Also Published As
Publication number | Publication date |
---|---|
JP5519960B2 (en) | 2014-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Oh et al. | Evaluation of probiotic properties of Lactobacillus and Pediococcus strains isolated from Omegisool, a traditionally fermented millet alcoholic beverage in Korea | |
Simonová et al. | Characterization of Staphylococcus xylosus and Staphylococcus carnosus isolated from Slovak meat products | |
CN101522887B (en) | Novel lactic acid bacteria | |
Park et al. | The probiotic characteristics and GABA production of Lactobacillus plantarum K154 isolated from kimchi | |
CN103857297A (en) | Probiotics in fruit beverages | |
JP5940780B2 (en) | Lactic acid bacteria isolated from traditional fermented foods in Ishikawa Prefecture, their cultures and their use | |
JP2006204296A5 (en) | ||
JP5519960B2 (en) | Lactic acid bacteria detection medium and detection method | |
JP5286424B2 (en) | Measuring method of viable count | |
Sobowale et al. | Energy sources of yoghurt bacteria and enhancement of their galactose uptake | |
ES2541220T3 (en) | Culture plate system and procedure for the improved detection of contaminating microorganisms of food products | |
Voidarou et al. | Hygienic quality and antibiotic resistance profile of sliced butchery | |
RU2701343C1 (en) | Nutrient medium for detection of lactic acid bacteria (versions) | |
US20040249129A1 (en) | Novel lactic bacteria of the genus lactococcus lactis and use thereof for preserving food products | |
WO2021005813A1 (en) | Culture medium for selectively separating lactic acid bacterium | |
Zacharof et al. | Development of an optimised growth strategy for intensive propagation, lactic acid and bacteriocin production of selected strains of Lactobacilli genus | |
Blaiotta et al. | Growth needs and culture media for LAB and dairy‐associated species | |
Barbu | Phenotypical characterization of several lactic acid bacteria strains isolated from wheat’s epiphyte microbiota | |
CN113699067B (en) | Lactobacillus helveticus, high-yield GABA (gamma-amino acid) direct vat set and application thereof | |
Matoulková et al. | Microbiology of brewing–Lactic Acid Bacteria and Cultivation Methods of their Detection–Part I | |
JP5401558B2 (en) | Method for measuring viable count and culture medium | |
EP1495109A1 (en) | Method of preparing a probiotic preparation | |
JP2009232717A (en) | Method for producing fermented milk using new lactic acid bacterium | |
JP6712126B2 (en) | Method for detecting microorganisms in food | |
JP2006136272A (en) | Semifluid medium for detecting lactobacillus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120612 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140114 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140305 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20140325 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140404 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5519960 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
R370 | Written measure of declining of transfer procedure |
Free format text: JAPANESE INTERMEDIATE CODE: R370 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |